用智能手机提供的自我帮助认知行为治疗失眠治疗抑郁症:一个并行组随机对照试验
Christian S Chan1, Christy Y F Wong1, Branda Y M Yu1
1The University of Hong Kong, Hong Kong.
Psychological medicine
|June 13, 2023
概括
一个智能手机应用程序有效地治疗了成年人的失眠和抑郁症状. 这种针对失眠的数字认知行为疗法 (CBT-I) 提供了一种方便且易于获得的心理健康解决方案.
科学领域:
- 数字心理健康干预数字心理健康干预
- 临床心理学 临床心理学
- 睡眠的药物 睡眠的药物
背景情况:
- 失眠的认知行为疗法 (CBT-I) 对伴随性抑郁症和失眠有效,但面临着可访问性和文化障碍.
- 基于智能手机的干预提供了一个低成本,方便的替代传统CBT-I.
- 这项研究研究了基于智能手机的自我辅助CBT-I对重大抑郁症和失眠的疗效.
研究的目的:
- 评估智能手机应用程序proACT-S在减少抑郁症和失眠严重性的有效性.
- 评估睡眠质量,焦虑和主观健康的改善.
- 为了确定基于智能手机的CBT-I治疗的可接受性.
主要方法:
- 一个平行组随机的,等候名单控制的试验,涉及320名患有严重抑郁症和失眠的成年人.
- 参与者接受了为期6周的基于智能手机的CBT-I (proACT-S) 或被列入等待名单.
- 主要结局包括抑郁症和失眠严重程度;次要结局包括焦虑和睡眠质量,评估在基线,6周和12周.
主要成果:
- 与等待名单组相比,治疗组在6周内显示出抑郁症 (科恩d = 0.86),失眠 (科恩d = 1.00) 和焦虑症 (科恩d = 0.83) 的显著减少.
- 在治疗组,睡眠质量显著改善 (科恩d=0.91).
- 在等待名单组接受治疗12周后,没有观察到任何显著差异.
结论:
- 基于智能手机的CBT-I (proACT-S) 是一种有效的自助治疗方法,适用于同时患有严重抑郁症和失眠的人.
- 像proACT-S这样的数字干预措施可以提高基于证据的心理健康护理的可访问性.
- 该研究支持使用移动健康应用程序来管理常见的心理健康状况.
相关概念视频
01:25Cognitive Therapy
183
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
183
01:19Management of Insomnia
284
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
284
01:27Insomnia
111
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
111
01:23Antidepressant Drugs: MAOIs and Other Agents
280
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
280
01:24Treatment Strategies for Psychological Disorders
176
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
176
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
453
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
453